Detalles de la búsqueda
1.
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysis.
Am J Hematol
; 99(5): 844-853, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38357714
2.
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT.
Am J Hematol
; 99(5): 993-996, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38385579
3.
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 129(23): 3735-3745, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658621
4.
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 98(4): 628-638, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36606718
5.
High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma.
Ann Hematol
; 100(7): 1755-1767, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33625572
6.
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry.
Am J Hematol
; 96(10): 1186-1194, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34152630
7.
Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT).
Am J Hematol
; 96(1): 69-79, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33064301
8.
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT.
Br J Haematol
; 190(3): 437-441, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32108327
9.
Increased Efficacy of Stem Cell Chemomobilization with Intermediate-Dose Cytarabine Plus Granulocyte Colony-Stimulating Factor (G-CSF) Compared with G-CSF Alone in Patients with Multiple Myeloma: Results of a Randomized Trial.
Biol Blood Marrow Transplant
; 25(2): 248-255, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30266677
10.
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(11): 2167-2171, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31284069
11.
Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT.
Br J Haematol
; 204(2): 715-718, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38014808
12.
Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMT.
Cancer
; 124(12): 2523-2533, 2018 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29603136
13.
Comparable safety profile of BeEAM (bendamustine, etoposide, cytarabine, melphalan) and BEAM (carmustine, etoposide, cytarabine, melphalan) as conditioning before autologous haematopoietic cell transplantation.
Contemp Oncol (Pozn)
; 22(2): 113-117, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30150889
14.
Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Cancer
; 123(5): 824-831, 2017 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27906458
15.
Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT.
Br J Haematol
; 198(1): 209-213, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482558
16.
Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis.
Br J Haematol
; 198(4): 785-789, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35658101
17.
Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 122(12): 1880-7, 2016 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27018549
18.
Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT.
Oncologist
; 21(3): 377-83, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26869584
19.
Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group.
Ann Hematol
; 95(2): 263-9, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26611854
20.
Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma.
Ann Hematol
; 100(7): 1919, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33760951